medigraphic.com

2014, Number 1

<< Back Next >>

Med Sur 2014; 21 (1)

Estado epiléptico refractario en el entorno de la terapia intensiva

Mata-Vicente JF, Rosales-Gutiérrez AO

Language: Spanish
References: 52
Page: 19-26
PDF size: 179.25 Kb.


ABSTRACT

The Status Epilepticus refers to the presence of a single relentless attack lasting more than 5 to 10 minutes or frequent clinical seizures without interictal return to baseline clinical status. The etiology include poor adherence to treatment, drug or alcohol withdrawal, acute brain injury or infection, and metabolic disorders. The prognosis depends on the etiology. In the diagnosis of status epilepticus, neurological examination and electroencephalogram, as well as initial evaluation and treatment of a patient in status epilepticus should run concurrently being essential. There are various approaches described for the treatment of status epilepticus. We recommend the approach described and summarized in the accompanying protocol (Grade 2C). Physicians should use medication regimens with them and care team are familiar with in order to prevent complications of therapy occur.


REFERENCES

  1. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980; 69: 657.

  2. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA 1993; 270: 854.

  3. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998; 338: 970.

  4. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12: 316.

  5. Chen J, Wasterlain C. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006; 5: 246-56.

  6. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005; 76: 534.

  7. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994; 35: 27.

  8. Logroscino G, Hesdorffer DC, Cascino G, et al. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997; 38: 1344.

  9. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990; 40: 9.

  10. Chapman MG, Smith M, Hirsch NP. Status epilepticus. Anaesthesia 2001; 56: 648.

  11. Chen DK, So YT, Fisher RS. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005; 65: 668.

  12. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol 2004; 11: 800.

  13. Koubeissi M, Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 2007; 69: 886.

  14. Canouï-Poitrine F, Bastuji-Garin S, Alonso E, et al. Risk and prognostic factors of status epilepticus in the elderly: a casecontrol study. Epilepsia 2011; 52: 1849.

  15. Legriel S, Azoulay E, Resche-Rigon M, et al. Functional outcome after convulsive status epilepticus. Crit Care Med 2010; 38: 2295.

  16. Limdi NA, Knowlton RK, Cofield SS, et al. Safety of rapid intravenous loading of valproate. Epilepsia 2007; 48: 478.

  17. Reiher J, Rivest J, Grand’Maison F, Leduc CP. Periodic lateralized epileptiform discharges with transitional rhythmic discharges: association with seizures. Electroencephalogr Clin Neurophysiol 1991; 78: 12.

  18. Tatum WO, Alavi A, Stecker MM. Technetium-99m-HMPAO SPECT in partial status epilepticus. J Nucl Med 1994; 35: 1087.

  19. Henry TR, Drury I, Brunberg JA, et al. Focal cerebral magnetic resonance changes associated with partial status epilepticus. Epilepsia 1994; 35: 35.

  20. Chu K, Kang DW, Kim JY, et al. Diffusion-weighted magnetic resonance imaging in nonconvulsive status epilepticus. Arch Neurol 2001; 58: 993.

  21. Briellmann RS, Wellard RM, Jackson GD. Seizure-associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia 2005; 46: 760.

  22. Privitera M, Hoffman M, Moore JL, Jester D. EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res 1994; 18: 155.

  23. Holtkamp M, Othman J, Buchheim K, Meierkord H. Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology 2006; 66: 1727.

  24. Walker MC, Smith SJ, Shorvon SD. The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia 1995; 50: 130.

  25. Treiman DM. Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia 1989; 30(Suppl. 2): S4.

  26. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992; 20: 483.

  27. Prensky AL, Raff MC, Moore MJ, Schwab RS. Intravenous diazepam in the treatment of prolonged seizure activity. N Engl J Med 1967; 276: 779.

  28. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2005; :CD003723.

  29. Wills B, Erickson T. Chemically induced seizures. Clin Lab Med 2006; 26: 185.

  30. Blake KV, Massey KL, Hendeles L, et al. Relative efficacy of phenytoin and phenobarbital for the prevention of theophyllineinduced seizures in mice. Ann Emerg Med 1988; 17: 1024.

  31. Coplin WM, Rhoney DH, Rebuck JA, et al. Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin. Neurol Res 2002; 24: 842.

  32. Swadron SP, Rudis MI, Azimian K, et al. A comparison of phenytoin- loading techniques in the emergency department. Acad Emerg Med 2004; 11: 244.

  33. Twyman RE, Rogers CJ, Macdonald RL. Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Ann Neurol 1989; 25: 213.

  34. Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988; 38: 202.

  35. Parviainen I, Uusaro A, Kälviäinen R, et al. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 2002; 59: 1249.

  36. Stecker MM, Kramer TH, Raps EC, et al. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998; 39: 18.

  37. Zarovnaya EL, Jobst BC, Harris BT. Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia 2007; 48: 1002.

  38. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000; 55: 722.

  39. Wheless JW, Vazquez BR, Kanner AM, et al. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004; 63: 1507.

  40. Hodges BM, Mazur JE. Intravenous valproate in status epilepticus. Ann Pharmacother 2001; 35: 1465.

  41. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006; 67: 340.

  42. Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007; 16: 527.

  43. Rossetti AO, Bromfield EB. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005; 65: 500.

  44. Towne AR, Garnett LK, Waterhouse EJ, et al. The use of topiramate in refractory status epilepticus. Neurology 2003; 60: 332. Órgano de Difusión de la Sociedad de Médicos Revista de Investigación

  45. Bensalem MK, Fakhoury TA. Topiramate and status epilepticus: report of three cases. Epilepsy Behav 2003; 4: 757.

  46. Reuber M, Evans J, Bamford JM. Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 2002; 9:111.

  47. Knake S, Gruener J, Hattemer K, et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008; 79: 588.

  48. Möddel G, Bunten S, Dobis C, et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry 2009; 80: 689.

  49. Eue S, Grumbt M, Müller M, Schulze A. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav 2009; 15: 467.

  50. Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011; 52: 1292.

  51. Höfler J, Unterberger I, Dobesberger J, et al. Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011; 52: e148.

  52. Marik PE, Varon J. The management of status epilepticus. Chest 2004; 126: 582.




2020     |     www.medigraphic.com